934963

[COVID19]

Death; This is a spontaneous report from a contactable Physician. An elderly male patient received BNT162B2 (COVID vaccine), via an unspecified route of administration on an unspecified date in Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced death in Jan2021. It was unknown if an autopsy was performed. It was unknown if any treatment was received for the event. It was unknown if the patient was

938059

[COVID19]

severe ITP; This is a spontaneous report from a contactable physician. A 22-years-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient developed severe ITP (Idiopathic thrombocytopenic purpura) on 20Dec2020, 3 days after first dose of the vaccine on 17Dec2020. He was hospitalize

940950

[COVID19]

thrombopenia; pulmonary embolism; neutropenia fever; This is a spontaneous report from a Pfizer-sponsored program . A contactable consumer reported for a patient that received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced thrombopenia, pulmonary embolism and neutropenia fever on an

951960

[UNK]

Thromboyctopenia; Started to feel sick; Massive brain bleed; A spontaneous report was received from a physician, concerning a male patient, who was also a physician, who received who received unconfirmed vaccine and experienced the events, started to feel sick, thrombocytopenia, and the fatal event, massive brain bleed. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 29 Dec 2020, prior to the onset of the events, the patient recei

955878

[COVID19]

his platelet levels dropped and he had a hemorrhagic stroke; his platelet levels dropped and he had a hemorrhagic stroke; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient died 2 weeks after his COVID shot bec

960437

[COVID19]

platelets dropped so low/thrombocytopenia; Hemorrhagic stroke/brain hemorrhage; This is a spontaneous report from a contactable nurse. A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. The reporter read about the doctor that died that developed thrombocytopenia after taking the vaccine, stated it was in the news

895071

[VARZOS]

erythematous emption of excoriated papules and pustules; erythematous emption of excoriated papules and pustules; Information has been received from a lawyer and a female patient (pt) of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On or around 07-MAR-2016, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot#, expiration date and route unknown) for routine health mainten

937985

[COVID19]

death following BNT 162b2 vaccination; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (COMIRNATY; PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as the first single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Death following BNT162B2 vaccination was noted on an unspecified date. The patient died on an

900087

[VARZOS]

Diagnosed with shingles in my right eye / was in the hospital Oct 29th to Nov 4th; Shingles in my right eye / was in the hospital Oct 29th to Nov 4th; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. In February 2019, the patient received the 1st dose of Shingrix. In August 2019,

906114

[FLU4]

anaphylactic shock; This case was reported by a consumer via call center representative and described the occurrence of anaphylactic shock in a adult female patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2019-2020 season) for prophylaxis. On an unknown date, the patient received FluLaval Tetra 2019-2020 season. On an unknown date, less than an hour after receiving FluLaval Tetra 2019-2020 season, the patient experienced anaphylactic shock (serious criteria hospitalization and GSK

489944

[FLUX,PPV]

This serious consumer report (initial receipt: 08-Apr-2013) concerns a female patient, who had a medical history of sinus surgery in 1993. Last year the patient received a flu shot (brand name, manufacturer and batch number were not reported). She also received an unspecified pneumonia shot at an unspecified time. In Jan-2013, Feb-2013 and Mar-2013, the patient had pneumonia. She also had the flu in Feb-2013. She went to the ER (Emergency Room) and was admitted at a hospital for pneumonia and fl

504698

[VARZOS,FLUX,PPV]

This spontaneous report as received from a pharmacist via company representative refers to a female patient of unknown age. Approximately on 28-AUG-2013 (reported as two weeks ago) the patient was vaccinated with a dose of PNEUMOVAX23, injection in the arm (dose, route, lot number and expiration date not provided). On the same date the patient was vaccinated with ZOSTAVAX and influenza virus vaccine (manufacturer unknown) in the other arm. The patient did have a reaction in the PNEUMOVAX23 arm.